BioCorRx (BICX) Equity Ratio (2016 - 2025)
BioCorRx (BICX) has disclosed Equity Ratio for 16 consecutive years, with 5.23 as the latest value for Q4 2025.
- Quarterly Equity Ratio rose 83.36% to 5.23 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5.23 through Dec 2025, up 83.36% year-over-year, with the annual reading at 5.23 for FY2025, 83.36% up from the prior year.
- Equity Ratio hit 5.23 in Q4 2025 for BioCorRx, down from 0.01 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 1.74 in Q1 2025 to a low of 34.24 in Q1 2024.
- Historically, Equity Ratio has averaged 12.0 across 5 years, with a median of 8.79 in 2022.
- Biggest five-year swings in Equity Ratio: plummeted 375.24% in 2022 and later soared 105.07% in 2025.
- Year by year, Equity Ratio stood at 8.49 in 2021, then decreased by 26.02% to 10.7 in 2022, then crashed by 139.2% to 25.59 in 2023, then decreased by 22.71% to 31.4 in 2024, then soared by 83.36% to 5.23 in 2025.
- Business Quant data shows Equity Ratio for BICX at 5.23 in Q4 2025, 0.01 in Q3 2025, and 1.74 in Q1 2025.